Show simple item record

dc.contributor.authorSchut, A-RW
dc.contributor.authorLidington, E
dc.contributor.authorTimbergen, MJM
dc.contributor.authorYounger, E
dc.contributor.authorvan der Graaf, WTA
dc.contributor.authorvan Houdt, WJ
dc.contributor.authorBonenkamp, JJ
dc.contributor.authorJones, RL
dc.contributor.authorGrünhagen, DJ
dc.contributor.authorSleijfer, S
dc.contributor.authorVerhoef, C
dc.contributor.authorGennatas, S
dc.contributor.authorHusson, O
dc.date.accessioned2022-04-26T15:04:23Z
dc.date.available2022-04-26T15:04:23Z
dc.date.issued2022-01-29
dc.identifier.citationCancers, 2022, 14 (3)
dc.identifier.issn2072-6694
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/5095
dc.identifier.eissn2072-6694
dc.identifier.eissn2072-6694
dc.identifier.doi10.3390/cancers14030709
dc.identifier.doi10.3390/cancers14030709
dc.description.abstractSporadic desmoid-type fibromatosis (DTF) is a rare, non-metastasising soft-tissue tumour. Patients can experience a variety of disease-specific issues related to the unpredictable clinical course and aggressiveness of DTF, which negatively impacts health-related quality of life (HRQoL). These DTF-specific issues are not captured by generic HRQoL tools. A 102-item provisional DTF-specific HRQoL tool, the DTF-QoL, was previously developed. The aim of this study was to pre-test the psychometric properties of the DTF-QoL by administering it together with the EORTC Quality of Life Questionnaire Core 30 (EORTC QLQ-C30) to 236 DTF patients from the United Kingdom and the Netherlands. Construct validity and reliability were determined based on factor analysis, multi-trait scaling analysis, Cronbach's alpha, and correlations with the EORTC QLQ-C30 scales. Ninety-six items were selected, conceptualised into three symptom scales, eleven disease-impact scales and six single items, together forming the final DTF-QoL. Scaling assumptions were fully or moderately met for ten out of fourteen scales. Cronbach's alpha ranged from 0.551-0.908. Most scales of the DTF-QoL were weakly or moderately correlated with the EORTC QLQ-C30. The DTF-QoL is a promising tool capturing the whole spectrum of DTF-specific issues. Implementation of the DTF-QoL in research and clinical practice will help to personalise HRQoL measurement and clinical care for DTF patients.
dc.formatElectronic
dc.languageeng
dc.language.isoeng
dc.publisherMDPI
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.titleDevelopment of a Disease-Specific Health-Related Quality of Life Questionnaire (DTF-QoL) for Patients with Desmoid-Type Fibromatosis.
dc.typeJournal Article
dcterms.dateAccepted2022-01-26
rioxxterms.versionVoR
rioxxterms.versionofrecord10.3390/cancers14030709
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2022-01-29
dc.relation.isPartOfCancers
pubs.issue3
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Clinical and Translational Sarcoma
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Sarcoma Clinical Trials (R Jones)
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Sarcoma Clinical Trials (R Jones)/Sarcoma Clinical Trials (R Jones) (hon.)
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.publication-statusPublished
pubs.volume14
pubs.embargo.termsNot known
icr.researchteamClinical and Translational Sarcoma
icr.researchteamSarcoma Clinical Trials (R Jones)
dc.contributor.icrauthorHusson, Olga


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

http://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/